Business · 29/10/20261 min read
Altruist Biologics' Integrated CMC Platform supports NMPA Acceptance of NDA for Localised Manufacturing of Multinational Client Biologic
Summary
HANGZHOU, China, Oct. 29, 2026 — Altruist Biologics, a world-class contract development and manufacturing organization (CDMO) and wholly owned subsidiary of Innovent Biologics (1801. HK), announced that...